Opdivo

Quote

anonymous said:
This is true unfortunately. Cafario has continued to make bad decisions and has assured BMS will be in the shitter on Wall Street. Look at what happened today. Opdivo flop and sell off a 2 billion dollar drug to finalize the Celgene deal which is looked upon as a terrible investment. These Wall Street warriors actually do know what is going on when deals are made. They do not have an agenda and just look at the facts. Look at BMS stock today. Worst day of any major pharmaceutical company this year. In a year where stocks are flying BMS is down for the year. Great job Cafario. And it is true Farxiga was sold off on Caforio’s watch. You are terrible. Resign!
Click to expand...
 

anonymous said:
Remember when Tom compared Opdivo and Keytruda to Pepsi and Coke? It’s very true, Keytruda is Coke and just like Coke dominating market share. Opdivo is Pepsi and barely holding on.
Click to expand...
How is holding on at all? The moron pod in my area works a total of about 2 hours per week, which probably consists of sitting around talking to each other. It’s pathetic to sell a drug at prices that bankrupt sick people who are dying and pay a salary to a bunch of thieves.
 
anonymous said:
How is holding on at all? The moron pod in my area works a total of about 2 hours per week, which probably consists of sitting around talking to each other. It’s pathetic to sell a drug at prices that bankrupt sick people who are dying and pay a salary to a bunch of thieves.
Click to expand...

That’s Pharma! Greedy fucks!
 
anonymous said:
Opdivo according to Cavario is doing better than Keytruda. HAHAHA!!!
Click to expand...
Cavario is an idiot. He got bested by Merck when BMS held all the cards. Greed to get all pt comers instead of methodically acquiring more and more indications cost Opdivo the leadership to Keytruda Merck is laughing all the way to the bank Check out the stock and how the tw companies have performed. Celgene has been a disappointment but then again Cavario made the call. Merck i# rocking because of Cavario
 
anonymous said:
Cavario is an idiot. He got bested by Merck when BMS held all the cards. Greed to get all pt comers instead of methodically acquiring more and more indications cost Opdivo the leadership to Keytruda Merck is laughing all the way to the bank Check out the stock and how the tw companies have performed. Celgene has been a disappointment but then again Cavario made the call. Merck i# rocking because of Cavario
Click to expand...

Bro...at least get his name right. Damn.
 
anonymous said:
Cavario is an idiot. He got bested by Merck when BMS held all the cards. Greed to get all pt comers instead of methodically acquiring more and more indications cost Opdivo the leadership to Keytruda Merck is laughing all the way to the bank Check out the stock and how the tw companies have performed. Celgene has been a disappointment but then again Cavario made the call. Merck i# rocking because of Cavario
Click to expand...

Any sales rep whose numbers performed the way our stock price has over the past few years would be fired. So why is the CEO secure in his job?
 
anonymous said:
Opdivo is done. BMY truly screwed up. The designer of their trials was an jdiot. No one would have ever known Keytruda is better than Opdivo if BMY would not have given Merck the opening
Click to expand...
Bristol Myers has a long and ugly history of screwing things up. Capoten vs. Vesotec; Venlev; Pravachol Prove-It trial; to name a few

Caforio’s performance compensation should be judged 100% based on share price growth - if ours is based on market share growth.
 
anonymous said:
Bristol Myers has a long and ugly history of screwing things up. Capoten vs. Vesotec; Venlev; Pravachol Prove-It trial; to name a few

Caforio’s performance compensation should be judged 100% based on share price growth - if ours is based on market share growth.
Click to expand...

You guys are all freaking dumbasses. His performance compensation should be based on revenue, just like everyone else’s. Company had the best revenue year EVER last year. And we all saw that reflected in our compensation. So just shut the fuck up and stop whining already. Goddamn.
 
anonymous said:
You guys are all freaking dumbasses. His performance compensation should be based on revenue, just like everyone else’s. Company had the best revenue year EVER last year. And we all saw that reflected in our compensation. So just shut the fuck up and stop whining already. Goddamn.
Click to expand...

So, everyone hit the top of plan? Everyone who “sells” Opdivo?
 
Here's some good news
Opdiva



anonymous said:
Cavario is an idiot. He got bested by Merck when BMS held all the cards. Greed to get all pt comers instead of methodically acquiring more and more indications cost Opdivo the leadership to Keytruda Merck is laughing all the way to the bank Check out the stock and how the tw companies have performed. Celgene has been a disappointment but then again Cavario made the call. Merck i# rocking because of Cavario
Click to expand...
 


Write your reply...
Top Bottom
Back
Quote